Abstract
Abstract
The full text of this preprint has been withdrawn by the authors due to author disagreement with the posting of the preprint. Therefore, the authors do not wish this work to be cited as a reference. Questions should be directed to the corresponding author.
Publisher
Research Square Platform LLC
Reference52 articles.
1. http://www.who.int/mediacentre/factsheets/fs317/en/
2. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets;Ramji DP;Cytokine Growth Factor Rev,2015
3. Matrix Metalloproteinase 2 Is Associated With Stable and Matrix Metalloproteinases 8 and 9 With Vulnerable Carotid Atherosclerotic Lesions;Sluijter JPG;Stroke,2006
4. Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling;Chen Q,2013
5. MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr-/-Apob100/100 mouse;Wågsäter DCZC;Int J Mol Med,2011